000 | 01881 a2200529 4500 | ||
---|---|---|---|
005 | 20250514211918.0 | ||
264 | 0 | _c20050104 | |
008 | 200501s 0 0 eng d | ||
022 | _a0016-5085 | ||
024 | 7 |
_a10.1053/j.gastro.2004.09.050 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZeuzem, Stefan | |
245 | 0 | 0 |
_aPeginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. _h[electronic resource] |
260 |
_bGastroenterology _cDec 2004 |
||
300 |
_a1724-32 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aRNA, Viral _xanalysis |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aDiago, Moisés | |
700 | 1 | _aGane, Edward | |
700 | 1 | _aReddy, K Rajender | |
700 | 1 | _aPockros, Paul | |
700 | 1 | _aPrati, Daniele | |
700 | 1 | _aShiffman, Mitchell | |
700 | 1 | _aFarci, Patrizia | |
700 | 1 | _aGitlin, Norman | |
700 | 1 | _aO'Brien, Christopher B | |
700 | 1 | _aLamour, François | |
700 | 1 | _aLardelli, Pilar | |
773 | 0 |
_tGastroenterology _gvol. 127 _gno. 6 _gp. 1724-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2004.09.050 _zAvailable from publisher's website |
999 |
_c15263450 _d15263450 |